Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study
European Journal of Surgical Oncology · 2026-09 · 52 (9) · 112019
DOI: 10.1016/j.ejso.2026.112019 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift European Journal of Surgical Oncology, 2026-09. Verfasst von Jacob L van Dam und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: j.l.vandam@erasmusmc.nl. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Postoperative Complications, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Benchmarking of surgical outcomes across institutions requires adjustment for established risk factors. Although pathological diagnosis is recognized as a determinant of postoperative morbidity after pancreatoduodenectomy, its independent impact on outcomes has not been systematically quantified at a national level. This study aimed to investigate the impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy and to assess inter-hospital variation in case-mix. METHODS: Data were obtained from the nationwide Dutch Pancreatic Cancer Audit. Postoperative complications were compared for pancreatic ductal adenocarcinoma (PDAC), distal cholangiocarcinoma (dCCA), ampullary adenocarcinoma (AAC), duodenal adenocarcinoma (DAC), non-invasive intraductal papillary mucinous neoplasm (IPMN), pancreatic neuroendocrine tumors (PanNET), chronic pancreatitis (CP), and Other Pathology. Multivariable logistic regression was used to identify independent risk factors for major complications (Clavien-Dindo grade ≥3). RESULTS: Between 2014 and 2020, 4152 patients underwent pancreatoduodenectomy. The three most common diagnoses were PDAC (n = 1778; 42.8%), dCCA (n = 544; 13.1%), and AAC (n = 541; 13.0%). The rate of major complications differed between diagnoses (P < 0.001), and was lowest for CP at 21.8% and highest for PanNET at 43.9%. All diagnoses except CP showed a higher risk of major complications compared with PDAC, with CP showing no significant difference. The adjusted odds ratio for major complications was the highest for PanNET (2.59; 95% CI: 1.84-3.65) and DAC (2.32; 95% CI: 1.77-3.03). CONCLUSIONS: Pathological diagnosis is an independent risk factor for complications after pancreatoduodenectomy, with PanNET and DAC carrying the highest risk. Given the substantial inter-hospital variation in case-mix, audits comparing postoperative outcomes across institutions should incorporate pathological diagnosis as a covariate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: j.l.vandam@erasmusmc.nl.
- Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
- Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Surgery, Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands.
- Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
Zitieren
APA
van Dam, J. L., van Dongen, J. C., Besselink, M. G., Bonsing, B. A., Bosscha, K., van Dam, R. M., Festen, S., van der Harst, E., de Hingh, I. H., Kazemier, G., Liem, M. S. L., de Meijer, V. E., Mieog, J. S. D., Molenaar, I. Q., Patijn, G. A., van Santvoort, H. C., van der Schelling, G. P., Stommel, M. W. J., Wit, F., …, & Dutch Pancreatic Cancer Group (2026). Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study. European Journal of Surgical Oncology, 52(9), 112019. https://doi.org/10.1016/j.ejso.2026.112019
Vancouver
van Dam JL, van Dongen JC, Besselink MG, Bonsing BA, Bosscha K, van Dam RM, et al. Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study. European Journal of Surgical Oncology. 2026;52(9):112019. doi:10.1016/j.ejso.2026.112019
BibTeX
@article{vanDam2026,
author = {van Dam, Jacob L and van Dongen, Jelle C and Besselink, Marc G and Bonsing, Bert A and Bosscha, Koop and van Dam, Ronald M and Festen, Sebastiaan and van der Harst, Erwin and de Hingh, Ignace H and Kazemier, Geert and Liem, Mike S L and de Meijer, Vincent E and Mieog, J Sven D and Molenaar, I Quintus and Patijn, Gijs A and van Santvoort, Hjalmar C and van der Schelling, George P and Stommel, Martijn W J and Wit, Fennie and de Wilde, Roeland F and van Eijck, Casper H J and Groot Koerkamp, Bas and Dutch Pancreatic Cancer Group, Dutch Pancreatic Cancer Group},
title = {Impact of pathological diagnosis on postoperative outcomes after pancreatoduodenectomy: A nationwide cohort study},
journal = {European Journal of Surgical Oncology},
year = {2026},
volume = {52},
number = {9},
pages = {112019},
doi = {10.1016/j.ejso.2026.112019}
}
EUVIMED